These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19538167)

  • 1. Titanium and vanadium complexes as anticancer agents.
    Kostova I
    Anticancer Agents Med Chem; 2009 Oct; 9(8):827-42. PubMed ID: 19538167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titanium complexes in cancer treatment.
    Meléndez E
    Crit Rev Oncol Hematol; 2002 Jun; 42(3):309-15. PubMed ID: 12050022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Benefits of Vanadium and Its Potential as an Anticancer Agent.
    Crans DC; Yang L; Haase A; Yang X
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
    Tshuva EY; Miller M
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spermicidal activity of metallocene complexes containing vanadium(IV) in humans.
    D'Cruz OJ; Ghosh P; Uckun FM
    Biol Reprod; 1998 Jun; 58(6):1515-26. PubMed ID: 9623614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanadium in cancer treatment.
    Evangelou AM
    Crit Rev Oncol Hematol; 2002 Jun; 42(3):249-65. PubMed ID: 12050018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy.
    Köpf-Maier P; Krahl D
    Chem Biol Interact; 1983 Jun; 44(3):317-28. PubMed ID: 6872095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells.
    Kowalski S; Wyrzykowski D; Inkielewicz-Stępniak I
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potentiality of vanadium in medicinal applications.
    Rehder D
    Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Arrest and Apoptosis Induced by the Next Generation of Vanadium Based Drugs: Action Mechanism to Structure Relation and Future Perspectives.
    Vlasiou MC; Pafiti KS
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2111-2116. PubMed ID: 33355058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
    Roy S; Chakraborty T
    Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of vanadium compounds.
    Djordjevic C
    Met Ions Biol Syst; 1995; 31():595-616. PubMed ID: 8564819
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumour metallocenes: structure-activity studies and interactions with biomolecules.
    Harding MM; Mokdsi G
    Curr Med Chem; 2000 Dec; 7(12):1289-303. PubMed ID: 11032972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumoral Titanium
    Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
    Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides.
    Köpf-Maier P; Wagner W; Köpf H
    Naturwissenschaften; 1981 May; 68(5):272-3. PubMed ID: 7242686
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
    Peri D; Meker S; Shavit M; Tshuva EY
    Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of vanadium compounds in therapeutics.
    Barrio DA; Etcheverry SB
    Curr Med Chem; 2010; 17(31):3632-42. PubMed ID: 20846114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.
    Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E
    J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic, Chemical, and Physical Properties of Organic Vanadates as Presumed Transition-State Inhibitors for Phosphatases.
    Crans DC
    J Org Chem; 2015 Dec; 80(24):11899-915. PubMed ID: 26544762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.